Published on DiabetesSource (http://www.diabetesproductsource.com)

TEVETEN® (eprosartan mesylate)

TEVETEN® (eprosartan mesylate) is an ARB indicated for the treatment of hypertension. Usual recommended starting dose is 600mg once daily when used as monotherapy in patients who are not volume-depleted. Typical daily dose range: administer once or twice daily with total daily dose ranging from 400mg to 800mg. Active Ingredients: eprosartan mesylate.

TEVETEN® (eprosartan mesylate) is an ARB indicated for the treatment of hypertension. Usual recommended starting dose is 600mg once daily when used as monotherapy in patients who are not volume-depleted. Typical daily dose range: administer once or twice daily with total daily dose ranging from 400mg to 800mg. Active Ingredients: eprosartan mesylate.

Product Category:
Blood Pressure Management
Sub-category:
Blood Pressure Medications
Product Features:
  • Contact manufacturer for further details
Other Features:
How Supplied/Sizing: 
Tablet: 400mg, 600mg. 100 per bottle.
Company information: 

Abbott Laboratories [1]

Street:
Pharmaceutical Products Division
Additional:
100 Abbott Park Rd.
City:
Abbott Park
,
Province:
Illinois
Postal Code:
60064-3500
Country:
United States

Broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health.

Website: 
www.abbott.com
Phone: 
847-937-6100
© 2008-2012 Kestrel Health Information, Inc. Legal notice | Privacy Policy
Source URL: http://www.diabetesproductsource.com/product/teveten-eprosartan-mesylate

Links:
[1] http://www.diabetesproductsource.com/company/abbott-laboratories